Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note 'No longer looking for participants'; standardized the label from 'Intervention / Treatment' to 'Intervention/Treatment', and updated the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page documentation.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page metadata.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now includes posted results with dates and the associated outcome measures, safety data, and QoL, plus links to the Study Protocol and Statistical Analysis Plan, reflecting updated documentation for the study record.SummaryDifference2%

- Check52 days agoChange DetectedA new citation was added for Amivantamab in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial (JAMA Otolaryngol Head Neck Surg, 2026 Apr 1). The prior online-ahead-of-print citation (Feb 26, 2026) was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThis updates the site’s displayed revision/version number from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.